NCT06126562
- Conditions
- Pharmacokinetic
- Locations
-
- The First Hospital of Jilin University Changchun, Jilin, China
Clinical trial condition
Pharmacokinetic
Explore clinical trials studying Pharmacokinetic. Study availability and eligibility vary by location and protocol.
29 public trials
1 recruiting study
Pharmacokinetic trial results
NCT03437265
- Conditions
- Pharmacokinetic
- Locations
-
- Quotient Sciences (Quotient), Ruddington, Nottingham, United Kingdom
NCT04959110
- Conditions
- Acute-On-Chronic Liver Failure, Citrate Toxicity, Continuous Renal Replacement Therapy, +11 more
- Locations
-
- Chulalongkorn university Bangkok, Thailand
Completed
Safety and Pharmacokinetics of Oral Controlled-ileocolonic-release Nicotinamide (CICR-NAM)
NCT05258474
- Conditions
- Digestive System Diseases, Gastroenteritis, Gastrointestinal Diseases, +4 more
- Locations
-
- University Medical Center Schleswig-Holstein Kiel, Germany
Completed
F573 Ia Clinical Trial
NCT04820049
- Conditions
- Pharmacokinetic, Tolerance
- Locations
-
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
Completed
A Study in Healthy Subjects to Evaluate Pharmacokinetics and Food Effect After Dosing of GS-248
NCT04617509
- Conditions
- Pharmacokinetic
- Locations
-
- Clinical Trial Consultants AB Uppsala, Sweden
Completed
A Clinical Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of Cebranopadol
NCT03882762
- Conditions
- Pharmacokinetic
- Locations
-
- US0001 Contract research organization Miami, Florida, United States
- US0002 Contract research organization Orlando, Florida, United States
NCT03958123
- Conditions
- Pharmacokinetic, Prolonged QTc Interval
- Locations
-
- US001 Contract research organization West Bend, Wisconsin, United States
NCT04708795
- Conditions
- Chemically-Induced Disorders, Marijuana Abuse, Mental Disorders, +4 more
- Locations
-
- Phase I Unit of CannaXan GmbH Warngau, Bavaria, Germany
Completed
Open-Label Study to Evaluate the Effect of Rifaximin on Midazolam in Normal Healthy Volunteers
NCT00743912
- Conditions
- Pharmacokinetic
- Locations
-
Not specified